Atyr Pharma's Q3 Loss: $0.26 per Share
Update: 2025-11-06
Description
Atyr Pharmas Q3 financials reveal a staggering loss of $25.7 million, or $0.26 per share, falling short of Wall Streets predictions. Despite a modest revenue of $190,000, the companys shares plummeted from $3.25 to $0.77, reflecting market concerns over their performance in the biotherapeutics sector.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
